Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • Drug-Linker Conjugates for ADC
    (1)
  • Endogenous Metabolite
    (1)
  • HDAC
    (1)
  • PROTAC Linker
    (1)
  • Reactive Oxygen Species
    (1)
  • Topoisomerase
    (1)
  • Others
    (5)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

edda

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Cell Research
    1
    TargetMol | Cell_Research_Reagents
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
EDDA
Ethylenediaminediacetic acid,, AI3-62471
T212075657-17-0
Ethylenediaminediacetic acid is derived from two molecules of glycine linked by amines.
  • $1,520
Inquiry
Size
QTY
Dodecylethyldimethylammonium bromide (EDDAB
Dodecylethyldimethylammonium bromide (EDDAB, Dimethyldodecylethylammonium bromide, 98%(T)
TSH-0046068207-00-1
Dodecylethyldimethylammonium bromide (EDDAB), 98%(T) [also known as Dimethyldodecylethylammonium bromide, 98%(T)], is a cationic surfactant.
  • Inquiry Price
7-10 days
Size
QTY
MCC-Modified Daunorubicinol
T18317721945-30-8
Daunorubicinol, a potent antitumor drug-linker conjugate for antibody-drug conjugate (ADC) applications, utilizes Aur0101 (DNA Topoisomerase II inhibitor) connected through the ADC linker[1].
  • Inquiry Price
Inquiry
Size
QTY
MNI-caged-D-aspartate
T23011845555-94-4
Agonist at NMDA receptors and EAAT substrate
  • $423
6-8 weeks
Size
QTY
NPEC-caged-D-AP5
T230811416943-27-5
NPEC-caged-D-AP5 is a NMDA receptor antagonist.
  • $1,520
6-8 weeks
Size
QTY
Antibacterial agent 254
T2018412418779-48-1
Antibacterialagent 254 (Compound 2) is an antimicrobial agent capable of eradicating 7-day-old P. aeruginosa biofilms at a concentration of 50 μM without affecting bacterial growth. Additionally, Antibacterialagent 254 enhances the efficacy of Ciprofloxacin against P. aeruginosa and upregulates the expression of the matrix-degrading enzyme genes pelA, pslG, and eddA.
  • Inquiry Price
10-14 weeks
Size
QTY